keep watching, and please do not buy.
I'm up over 50% in 7 trading day since you wandered over here...talk about ill timing...LOL, but good for us holders loaded up at lows.
The trial design will be up soon enough...The proposed clinical study
The pre-clinical study results, which have been published in American Journal of Respiratory and Critical Care Medicine (AJRCCM), provide a sound basis for progressing to a clinical study. Cynata has received approval to undertake a clinical trial to investigate early efficacy of Cynata’s proprietary Cymerus MSCs in adults admitted to intensive care with COVID-19. Twelve patients will be randomised to receive Cymerus MSC infusions, in addition to standard of care, while 12 patients will be randomised to the control group and will receive current standard of care.
The primary efficacy endpoint will be improvement in PaO2/FiO2 ratio (a measure of hypoxemia, a low level of oxygen in the blood caused by compromised lung function) by Day 7. Safety and tolerability up to Day 28 will also be a primary endpoint.
Recruitment is expected to commence subject to finalisation of relevant agreements with study centres in New South Wales, Australia.
https://www.cynata.com/acute-respiratory-distress-syndrome
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.89M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $30.92K | 205.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 53229 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 479 | 1 |
View Market Depth
| Last trade - 15.53pm 17/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |